
This dataset catalogs coverage positions and gatekeeping requirements for four ketamine therapy modalities (Spravato, IV, IM, oral/sublingual) across 18 major U.S. commercial insurers, including policy URLs and last-updated dates.
esketamine, spravato, commercial insurance, ketamine therapy, IV ketamiine, insurance coverage
esketamine, spravato, commercial insurance, ketamine therapy, IV ketamiine, insurance coverage
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
